MPT0E028, identified by its CAS number 1338320-94-7, is a chemical compound that has garnered interest in various fields, particularly in medicinal chemistry and drug development. While specific characteristics such as its molecular structure, physical properties, and biological activity may not be widely documented in public databases, compounds like MPT0E028 are typically evaluated for their potential therapeutic effects, including their mechanism of action, efficacy, and safety profiles. Such substances may exhibit properties like solubility in various solvents, stability under different conditions, and specific reactivity with biological targets. Researchers often investigate these compounds for their roles in disease treatment, particularly in oncology or neurology, where novel agents are continuously sought. For precise details regarding its characteristics, including its synthesis, pharmacokinetics, and toxicology, consulting specialized scientific literature or databases would be essential, as these aspects are crucial for understanding the compound's potential applications and implications in research and medicine.

MPT0E028

1338320-94-7: MPT0E028, identified by its CAS number 1338320-94-7, is a chemical compound that has garnered interest in various fields, particularly in medicinal chemistry and drug development. While specific characteristics such as its molecular structure, physical properties, and biological activity may not be widely documented in public databases, compounds like MPT0E028 are typically evaluated for their potential therapeutic effects, including their mechanism of action, efficacy, and safety profiles. Such substances may exhibit properties like solubility in various solvents, stability under different conditions, and specific reactivity with biological targets. Researchers often investigate these compounds for their roles in disease treatment, particularly in oncology or neurology, where novel agents are continuously sought. For precise details regarding its characteristics, including its synthesis, pharmacokinetics, and toxicology, consulting specialized scientific literature or databases would be essential, as these aspects are crucial for understanding the compound's potential applications and implications in research and medicine.

<p>3-(1-Benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide is a peptide that is an activator of the GABAA receptor. This compound binds to the benzodiazepine site on the receptor and increases chloride ion conductance. 3-(1-Benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide inhibits the binding of glutamate to NMDA receptors, which leads to less calcium influx into cells. It also has a high affinity for GABA receptors and is used as a research tool in cell biology and pharmacology.</p>

3-(1-Benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide

<p>Imofinostat (MPT0E028) is a selective, orally available pan-HDAC inhibitor with IC₅₀ values of 53.0/106.2/29.5 nM against HDAC1/HDAC2/HDAC6 in HCT116 cells.</p>

CAS 1338320-94-7

MPT0E028

3-(1-Benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide

Ref: 3D-NDC32094

Imofinostat

Ref: TM-T16131